Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-platelet Therapy, in Patients Undergoing High-risk Coronary Angioplasty [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of abciximab as anti-platelet therapy in patients undergoing high-risk percutaneous coronary angioplasty; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Unstable Angina

Drugs mentioned

• ReoPro (abciximab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Angina, Unstable, Angioplasty, Transluminal, Percutaneous Coronary | Phase 3 | Status: COMPLETED